Inhibition of TGF-β ligands effectively abolished chemoradiation-induced EMT, indicating that chemoradiation contributed to resistant metastatic disease in EAC patients by aTGF-β-dependent EMT induction. The gene discussed is TGFB1; the disease is metastatic neoplasm.